Sequence information
Variant position: 342 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 419 The length of the canonical sequence.
Location on the sequence:
MYWTMLQQLTHHSVNGCNLR
P GDLLASGTISGPEPENFGSM
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MYWTMLQQLTHHSVNGCNLRP GDLLASGTISGPEPENFGSM
Mouse MYWTMLQQLTHHSVNGCNLRP GDLLASGTISGSDPESFGSM
Rat MYWTILQQLTHHSVNGCNLRP GDLLASGTISGSDPESFGSM
Bovine MYWTMLQQLTHHSVNGCNLQP GDLLASGTISGPEPESFGCM
Caenorhabditis elegans LYWTLKQQLAHHTVNGCNLRA GDLLGSGTVSGPEEGAYGSM
Slime mold MYWTLTQQLAHHTVNGCNMNA GDLLGTGTISGPTEDSYGSM
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 419
Fumarylacetoacetase
Binding site
350 – 350
Literature citations
Two missense mutations causing tyrosinemia type 1 with presence and absence of immunoreactive fumarylacetoacetase.
Rootwelt H.; Chou J.; Gahl W.A.; Berger R.; Coskun T.; Brodtkorb E.; Kvittingen E.A.;
Hum. Genet. 93:615-619(1994)
Cited for: VARIANTS TYRSN1 ASP-134 AND LEU-342;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.